AJP - Heart Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H1770-H1776, 2005. First published November 18, 2004; doi:10.1152/ajpheart.00751.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/4/H1770    most recent
00751.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nishimatsu, H.
Right arrow Articles by Hirata, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nishimatsu, H.
Right arrow Articles by Hirata, Y.

Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats

Hiroaki Nishimatsu,1 Etsu Suzuki,2 Hiroshi Satonaka,2 Ryo Takeda,2 Masao Omata,2 Toshiro Fujita,2 Ryozo Nagai,2 Tadaichi Kitamura,1 and Yasunobu Hirata2

1Departments of Urology and 2Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Tokyo, Japan

Submitted 27 July 2004 ; accepted in final form 13 November 2004

To study the mechanisms of vascular dysfunction in diabetes mellitus, we examined the responses of the aorta to adrenomedullin (AM) and ANG II in obese Zucker (OZ), lean Zucker (LZ), and OZ rats administered fluvastatin (OZ + Flu). AM-induced endothelium-dependent vasorelaxation was impaired in OZ rats compared with LZ rats, and fluvastatin restored AM-induced, endothelium-dependent vasorelaxation (%{Delta}tension at 10–7 mol/l AM; LZ, –85.1 ± 3.1%; OZ, –50.7 ± 2.5%; OZ + Flu, –75.6 ± 2.7%). Expression of endothelial nitric oxide synthase (eNOS) and Akt phosphorylation in response to AM (10–7 mol/l) were also diminished in OZ rats. Fluvastatin restored the eNOS expression and Akt phosphorylation [eNOS expression (relative intensity): LZ, 2.3 ± 0.4; OZ, 1.0 ± 0.2; OZ + Flu, 1.8 ± 0.3; Akt phosphorylation (relative intensity): LZ, 2.3 ± 0.2; OZ, 1.0 ± 0.3; OZ + Flu, 1.9 ± 0.2]. ANG II-induced vasoconstriction was enhanced in the aortic rings of OZ rats compared with LZ rats, and this enhanced vasoconstriction was partially normalized by fluvastatin and was abolished when the aorta of OZ rats was preincubated with the Rho kinase inhibitor Y-27632. GTP{gamma}S-induced contraction of permeabilized aortic smooth muscle cells, which is an indicator of the Rho-dependent Ca2+ sensitization of contraction, was enhanced in OZ rats compared with LZ rats, and this enhanced contraction was suppressed in OZ + Flu rats. These results suggested that endothelium-dependent vasorelaxation was impaired, Ca2+ sensitization of contraction was augmented in blood vessels of OZ rats and that fluvastatin restored vascular function by activating the Akt-dependent pathway and inhibiting the Rho-dependent pathway.

nitric oxide; Akt; Rho



Address for reprint requests and other correspondence: E. Suzuki, Division of Nephrology and Endocrinology, #202, The Dept. of Internal Medicine, Faculty of Medicine, Univ. of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655 Japan (E-mail: suzuki-2im{at}h.u-tokyo.ac.jp)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Serpillon, B. C. Floyd, R. S. Gupte, S. George, M. Kozicky, V. Neito, F. Recchia, W. Stanley, M. S. Wolin, and S. A. Gupte
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H153 - H162.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Korda, R. Kubant, S. Patton, and T. Malinski
Leptin-induced endothelial dysfunction in obesity
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1514 - H1521.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. H. Siddiqui and T. Hussain
Enhanced AT1 receptor-mediated vasocontractile response to ANG II in endothelium-denuded aorta of obese Zucker rats
Am J Physiol Heart Circ Physiol, April 1, 2007; 292(4): H1722 - H1727.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. Barbato, B. S. Zuckerbraun, M. Overhaus, K. G. Raman, and E. Tzeng
Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and the metabolic syndrome
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H228 - H236.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.